Aktive Positionen von Heiko von der Leyen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ORGENESIS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2020 | - |
Karriereverlauf von Heiko von der Leyen
Ehemalige bekannte Positionen von Heiko von der Leyen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Hannover Clinical Trial Center GmbH | Corporate Officer/Principal | 01.01.2005 | 01.01.2017 |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 | 01.01.2004 |
Artiss GmbH | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | 01.01.2002 |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 | 01.01.2001 |
Statistik
International
Deutschland | 5 |
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ORGENESIS INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Hannover Clinical Trial Center GmbH | |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development. | Health Technology |
Artiss GmbH | |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | Health Technology |
- Börse
- Insiders
- Heiko von der Leyen
- Erfahrung